Sort   by:  
 Page size 
UnknownThe promises of quantitative systems pharmacology modelling for drug development.
Not available
S-EPMC5064996 | biostudies-literature
UnknownASPASIA: A toolkit for evaluating the effects of biological interventions on SBML model behaviour.
Not available
S-EPMC5315406 | biostudies-literature
UnknownTargeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies.
Not available
S-EPMC8793278 | biostudies-literature
UnknownAgent-Based Modeling in Systems Pharmacology.
Not available
S-EPMC4716580 | biostudies-literature
UnknownImmune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen.
Not available
S-EPMC8107731 | biostudies-literature
UnknownCOVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.
Not available
S-EPMC9047221 | biostudies-literature
UnknownCharacterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C.
Not available
S-EPMC10616300 | biostudies-literature
UnknownTranscriptomic and genetic studies identify NFAT5 as a candidate gene for cocaine dependence.
Not available
S-EPMC4930134 | biostudies-literature
UnknownCurrent practices for QSP model assessment: an IQ consortium survey.
Not available
S-EPMC9371373 | biostudies-literature
UnknownExpanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected and Unexpected Findings.
Not available
S-EPMC6797824 | biostudies-literature
Sort   by:  
 Page size